Ishikawa, J., Matsumura, I., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., … Kanakura, Y. (2018). Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial). International Journal of Hematology. https://doi.org/10.1007/s12185-018-2401-y (Original work published 2018)